ALGN
Align Technology, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$158.64
−0.76%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.1B | 4.0B | 4.0B | 3.9B | 3.7B |
| Cost of Revenue | 1.4B | 1.3B | 1.2B | 1.2B | 1.1B |
| Gross Profit | 2.8B | 2.8B | 2.8B | 2.7B | 2.6B |
| Operating Expenses | |||||
| R&D Expense | 377.0M | 369.9M | 364.2M | 346.8M | 305.3M |
| SG&A Expense | 1.8B | 1.8B | 1.8B | 1.7B | 1.7B |
| General & Admin Expense | — | — | 1.6B | — | — |
| Selling & Marketing Expense | — | — | 185.0M | — | — |
| Other Expenses | 36.6M | 15.0M | 64.1M | 13.3M | 11.5M |
| Total Operating Expenses | 2.2B | 2.1B | 2.2B | 2.1B | 2.0B |
| Cost and Expenses | 3.6B | 3.4B | 3.4B | 3.2B | 3.1B |
| Operating Income (EBIT) | 551.9M | 616.2M | 607.6M | 643.3M | 642.6M |
| Non-Operating | |||||
| Interest Income | 16.4M | 16.0M | 20.2M | 17.3M | 5.4M |
| Interest Expense | 1.6M | — | — | — | — |
| Net Interest Income | 14.9M | 16.0M | 20.2M | 17.3M | 5.4M |
| Other Non-Op Income/Expense | 17.0M | (30.9M) | 1.3M | (2.1M) | (43.5M) |
| Non-Operating Income (excl Interest) | (76.8M) | 30.9M | (64.1M) | (13.3M) | (11.5M) |
| EBT (Pre-Tax Income) | 568.9M | 585.3M | 609.0M | 641.2M | 599.1M |
| Income Tax Expense | 155.3M | 174.9M | 187.6M | 196.2M | 237.5M |
| Bottom Line | |||||
| Net Income | 413.6M | 410.4M | 421.4M | 445.1M | 361.6M |
| Earnings from Cont. Ops | 413.6M | 410.4M | 421.4M | 445.1M | 361.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 413.6M | 410.4M | 421.4M | 445.1M | 361.6M |
| Per Share | |||||
| Basic EPS | $5.76 | $5.66 | $5.63 | $5.82 | $4.62 |
| Diluted EPS | $5.76 | $5.65 | $5.62 | $5.81 | $4.61 |
| Revenue Per Share | $57.93 | $55.62 | $53.41 | $50.54 | $47.76 |
| Shares | |||||
| Basic Shares Outstanding | 71.5M | 72.5M | 74.9M | 76.4M | 78.2M |
| Diluted Shares Outstanding | 71.6M | 72.6M | 75.0M | 76.6M | 78.4M |
| Profitability Metrics | |||||
| EBITDA | 786.3M | 765.9M | 816.8M | 799.1M | 779.8M |
| D&A | 157.7M | 180.6M | 145.0M | 142.4M | 125.8M |
| EBIT | 628.6M | 585.3M | 671.8M | 656.7M | 654.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026